Viking Therapeutics VKTX
NASDAQ VKTX
$26.38 -0.33 (-1.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Total Current Liabilities (2014 - 2026)

Updated

Viking Therapeutics' Total Current Liabilities came in at $109.66 million for Q2 2026, up 242.9% from $31.98 million a year earlier and up 3.1% from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Total Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Viking Therapeutics' Total Current Liabilities was $76.67 million, up 179.7% from FY2024.

  • Total Current Liabilities carries a five-year compound annual growth rate of 44.6% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $27.41 million in FY2024 (+43.3%), $19.14 million in FY2023 (-12.8%), $21.95 million in FY2022 (+150.0%) and $8.78 million in FY2021 (-27.6%).
  • The Q2 2026 figure represents the highest quarterly Total Current Liabilities in data going back to Q4 2014.
  • Year-over-year, Total Current Liabilities has increased for five consecutive quarters, with growth averaging 123.7% over the last eight quarters.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q1 2026 (growth of 443.2%), and the weakest in Q1 2025 (a decline of 40.3%).
  • Business Quant data shows VKTX's Total Current Liabilities at $106.33 million (Q1 2026), $76.67 million (Q4 2025) and $26.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Viking Therapeutics 3.07 Bn 545.20 Mn - 109.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 109.66 Mn
Mar 31, 2026 106.33 Mn
Dec 31, 2025 76.67 Mn
Sep 30, 2025 26.07 Mn
Jun 30, 2025 31.98 Mn
Mar 31, 2025 19.57 Mn
Dec 31, 2024 27.41 Mn
Sep 30, 2024 25.69 Mn
Jun 30, 2024 25.09 Mn
Mar 31, 2024 32.77 Mn
Dec 31, 2023 19.14 Mn
Sep 30, 2023 13.41 Mn
Jun 30, 2023 13.48 Mn
Mar 31, 2023 15.65 Mn
Dec 31, 2022 21.95 Mn
Sep 30, 2022 14.06 Mn
Jun 30, 2022 14.86 Mn
Mar 31, 2022 11.27 Mn
Dec 31, 2021 8.78 Mn
Sep 30, 2021 11.35 Mn
API Access

Viking Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=VKTX&period=max&api_key=YOUR_API_KEY